BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26113408)

  • 1. High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma.
    Zhang B; Cheng B; Li FS; Ding JH; Feng YY; Zhuo GZ; Wei HF; Zhao K
    Tumour Biol; 2015 Dec; 36(12):9411-9. PubMed ID: 26113408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma.
    Zhang B; Song B; Wang X; Chang XS; Pang T; Zhang X; Yin K; Fang GE
    Tumour Biol; 2015 Jul; 36(7):5459-66. PubMed ID: 25677906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma".
    Antonioli L; di Paolo A; Fornai M; Danesi R; Blandizzi C
    Tumour Biol; 2015 Sep; 36(10):7397-8. PubMed ID: 26383525
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
    Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z
    J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer.
    Bareche Y; Pommey S; Carneiro M; Buisseret L; Cousineau I; Thebault P; Chrobak P; Communal L; Allard D; Robson SC; Mes-Masson AM; Provencher D; Lapointe R; Stagg J
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium.
    Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression.
    Kim ES; Ackermann C; Tóth I; Dierks P; Eberhard JM; Wroblewski R; Scherg F; Geyer M; Schmidt RE; Beisel C; Bockhorn M; Haag F; van Lunzen J; Schulze Zur Wiesch J
    J Leukoc Biol; 2017 May; 101(5):1263-1271. PubMed ID: 28193736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
    Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
    J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study.
    Lima CF; Tamegnon A; Rodriguez S; Maru D; Martin PL; Cooper ZA; Rodriguez-Canales J; Parra ER
    Pathobiology; 2024; 91(3):205-218. PubMed ID: 37926083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.
    De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.
    Synnestvedt K; Furuta GT; Comerford KM; Louis N; Karhausen J; Eltzschig HK; Hansen KR; Thompson LF; Colgan SP
    J Clin Invest; 2002 Oct; 110(7):993-1002. PubMed ID: 12370277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous accurate quantification of HO-1, CD39, and CD73 in human calcified aortic valves using multiple enzyme digestion - filter aided sample pretreatment (MED-FASP) method and targeted proteomics.
    Olkowicz M; Jablonska P; Rogowski J; Smolenski RT
    Talanta; 2018 May; 182():492-499. PubMed ID: 29501184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
    Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
    FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
    Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
    Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
    Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
    Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
    Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
    Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure.
    Tak E; Jung DH; Kim SH; Park GC; Jun DY; Lee J; Jung BH; Kirchner VA; Hwang S; Song GW; Lee SG
    Toxicol Appl Pharmacol; 2017 Jan; 314():72-81. PubMed ID: 27899277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
    Perrot I; Michaud HA; Giraudon-Paoli M; Augier S; Docquier A; Gros L; Courtois R; Déjou C; Jecko D; Becquart O; Rispaud-Blanc H; Gauthier L; Rossi B; Chanteux S; Gourdin N; Amigues B; Roussel A; Bensussan A; Eliaou JF; Bastid J; Romagné F; Morel Y; Narni-Mancinelli E; Vivier E; Paturel C; Bonnefoy N
    Cell Rep; 2019 May; 27(8):2411-2425.e9. PubMed ID: 31116985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
    Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.